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Background: This is a case report of cortical blindness in a HIV-positive patient with progressive multifocal
leukoencephalopathy (PML) without any other associated neurological dysfunction.
Findings: Young HIV-positive patient presented to us with sudden profound visual loss. On examination and
further investigation, we have diagnosed cortical blindness without any other focal neurological deficit due to PML.
Conclusion: Our case highlights the fact that PML needs to be suspected in patients with HIV, presenting with
cortical blindness even without any other focal neurological defect.
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Introduction
Progressive multifocal leukoencephalopathy (PML) is a
demyelinating disorder of the central nervous system
(CNS) found in immune-deficient patients. It is caused
by John Cunningham virus, a human polyomavirus (DNA
virus) belonging to Papovaviridae group [1]. PML was ori-
ginally described in patients with chronic diseases asso-
ciated with compromised immune response or with
immunosuppressive drugs [2,3]. However, the disease has
been most frequently documented in patients with
acquired immunodeficiency syndrome (AIDS) [4,5]. Stu-
dies estimate that prior to effective antiretroviral therapy,
as many as 5% of people with AIDS eventually developed
PML [6]. Usually, the outcome of patients of PML is poor;
the disease is most often rapidly fatal with an expected
progression to death within 6 months of symptoms [6,7].
Demyelination of the CNS is a consequence of virus-
induced killing of oligodendrocytes, although the exact
mechanism of cell death is unknown.* Correspondence: vijaymedic@gmail.com
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logical deficits, generally without fever or headache. The
progression of deficits leads to life-threatening disability
and death over weeks to months. Neuroimaging plays a
crucial role in the early diagnosis and longitudinal moni-
toring of functional integrity of the nervous system.
Since the central visual pathways and brainstem may be
affected, a variety of neuro-ophthalmic signs and symp-
toms may manifest like visual symptoms, nystagmus, and
cranial nerve and supranuclear gaze palsies [8,9]. Visual
symptoms alone are infrequent in PML. We report a
patient who presented with cortical blindness and without
any other associated neurological dysfunction. Cortical
blindness refers to visual loss in the presence of normal
fundus and normal pupillary light reactions. It implies bi-
lateral disease affecting the optic radiation or occipital
lobes, most commonly caused by bilateral occipital lobe
ischemia or trauma.
Case report
A 34-year-old, recently diagnosed HIV-positive male
presented to us with complaints of sudden painless
decrease in vision in both eyes, 1 week before. On oculars is an Open Access article distributed under the terms of the Creative Commons
rg/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction
properly cited.
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direct ophthalmoscope in dark room. Pupils were equal
in size, and direct and consensual reflexes were normal.
Ocular movements were full. Anterior segment slit lamp
biomicroscopy and fundus examination with indirect
ophthalmoscope were clinically within the normal limits.
Systemic evaluation revealed no definite focal neuro-
logical deficits.Figure 1 VEP showing a non-recordable response.A clinical diagnosis of cortical blindness was made.
The patient underwent visual evoked potential (VEP)
and magnetic resonance imaging (MRI). VEP showed
non-recordable response (Figure 1). Axial T2-Flair MRI
of the brain and orbit (Figure 2a) showed hyperintense
signal intensity lesions bilaterally in the parieto-occipital
white matter. Axial T2-Flair diffuse-weighted image
(Figure 2b) showed hyperintense lesions bilaterally in the
Figure 2 Axial T2-Flair MRI and axial T2-Flair diffuse-weighted image. (a) Axial T2-Flair MRI of the brain showing hyperintense signal
intensity lesions bilaterally in the parieto-occipital white matter. (b) Axial T2-Flair diffuse-weighted image showing hyperintense lesions bilaterally
in the parieto-occipital white matter.
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elevated lactate and choline peak and reduction in the
N-acetyl aspartate (NAA). These features were suggestive
of demyelination. Optic nerve course, caliber, and signals
were within the normal limits. Patient was evaluated sys-
temically by the AIDS care physician and neurologist.
Clinically, no cognitive or neurological deficits or other
manifestations related to parieto-occipital and frontal dis-
ease were found. Patient CD4 count was 104 cells/mm3.
Blood and CSF analyses to rule out other neurological ill-
ness commonly seen in patients with HIV such as cerebral
tuberculosis, toxoplasmosis, Cryptococcus infection, or
lymphoma were negative. The patient was initiated on
highly active antiretroviral therapy (HAART) but refused
inpatient treatment. Patient was brought to us few weeks
later in an unresponsive state with terminal neurological
illness and died within few hours.
Discussion
PML has varied cerebral and brainstem manifestations.
Most common initial manifestations are hemiparesis,
mental deterioration, dysarthria, and dysphasia [2,5].
Although 20% to 30% of patients with HIV/AIDS can
present with associated ocular manifestations at the
time of diagnosis of PML [9], ocular involvement as
the initial manifestation is rarely seen [3,10]. Patients
presenting as hemianopic field defects and retrochiasmal
field defects have been reported [5-9]. Most patients with
PML have focal neurological deficits at the time of ocular
manifestations.
Our patient presented with cortical blindness as a pri-
mary manifestation due to demyelination of bilateral oc-
cipital lobe involvement. There were no other systemic
features attributable to PML. In spite of initiation on
HAART, our patient died within few weeks of diagnosis.HIV encephalopathy, cerebral tuberculosis, toxoplas-
mosis, lymphoma, Cryptococcus infection, and cerebral
infarction need to be considered in the differential diag-
nosis in patients with HIV infection presenting with
neurological illness [7]. Clinical features and neuroima-
ging were helpful in differentiating these conditions
from PML as seen in our case.
MRI typically reveals multiple non-enhancing white
matter lesions that may coalesce and have a predilection
for the occipital and parietal lobes. The lesions show
T2 hyper-intensity signals and diminished signal in
T1-weighted images.
Recent improvements in newer imaging techniques
like MR spectroscopy are replacing the older invasive
methods for diagnosing PML. On MR spectroscopy,
there is decreased NAA with significantly decreased
NAA/creatinine ratio with increased choline and lactate
peak [11] as noted in our patient. A diagnosis of PML in
our case was made based on the presentation of a
cortical blindness, rapidly progressive course of the
disease, and MRI and MR spectroscopy scans consistent
with PML.
Finsterer et al. [12] reported a patient presenting with
cortical blindness along with bradydiadochokinesia and
left ventricular hypertrabeculation/noncompaction. They
also concluded that they may not have a causal rela-
tionship. Rickards and Shepherd also reported a pa-
tient with cortical blindness as the initial manifestation in
PML [10]. Unlike our case, his patient had a progressive
tunnel vision with associated neurological signs such as
hemiparesis. Cortical blindness with PML has always been
reported in the literature to be associated with other
neurological deficits [9]. In our patient, cortical blindness
was the only presenting feature and had no other asso-
ciated neurological dysfunction.
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Our case highlights the fact that PML needs to be sus-
pected in patients with HIV, presenting with cortical
blindness even without any other focal neurological
deficits. This case also illustrates the need of a prompt
diagnosis in order to treat the patient as soon as pos-
sible considering the rapid evolution of the disease.
We had not come across, after Medline search, any
such report of a patient with HIV presenting with cor-
tical blindness as the presenting feature of PML with-
out other neurological deficits.Ethics
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